Mirati Therapeutics, Inc. - New frontiers in the treatment of advanced NSCLC (ID 40) Industry Satellite Symposium

Treatment landscape for advanced NSCLC: Where are we now?

Lecture Time
11:35 - 11:55
Speakers
  • J. Wolf (Cologne, Germany)
Authors
  • J. Wolf (Cologne, Germany)
Session Name
Mirati Therapeutics, Inc. - New frontiers in the treatment of advanced NSCLC (ID 40)
Date
Wed, 29.03.2023
Time
11:30 - 13:00
Room
Auditorium 2